251 - 275 of 8,106
Number of results to display per page
TitleCreatorRelation Is Part Of
251 A Not So Sweet Case of PapilledemaMeari Taguchi, Wayne Cornblath, Sangeeta Khanna, Lindsey De Lott, Tatiana Deveney, Hemant Parmar, Emile PinarbasiNANOS Annual Meeting 2023: Walsh Society Session III: "Tomorrowland" : Learning From Pediatric Neuro-Ophthalmic Disorders: https://novel.utah.edu/collection/NAM/toc/
252 A Novel Approach to Measuring Peripapillary Retinal Perfusion in Papilledema: A Pilot Study Using Optical Coherence Tomography Angiography (.pdf)David Fell; Nicole K. Scripsema; Sarita B. Dave; Charles Lopresto; Patricia M. Garcia; Rudrani BanikNANOS Annual Meeting 2016: Scientific Platform Session II
253 A Novel Device to Measure Critical Flicker Fusion FrequencyKathleen Daetwyler; Paul Borgmeier; Kathleen Digre; Judith Warner; Donnel Creel; David Weinberg; Bradley KatzNANOS 2007: Poster Presentations
254 A Novel Diagnostic Tool for Myasthenia Gravis: Ocular Vestibular Evoked Myogenic Potentials (oVEMP)Konrad P. Weber; Yulia Valko; Sally M. Rosengren; Hans H. Jung; Dominik Straumann; Klara LandauNANOS Annual Meeting 2015 Platform Session 2
255 A Novel Hand Held Instrument for Quantitating Diplopic Visual FieldsDavid BardensteinNANOS 2014: Poster Presentations
256 A Novel Mechanism for the Central Nervous System Transit of Aquaporin-4 Autoantibody in Neuromyelitis Optica (abstract)Jeffrey Bennett; Fumitaka Shimizu; Kristin Schaller; Gregory Owens; Anne Cotleur; Debra Kellner; Yukio Takeshita; Birgit Obermeier; Thomas Kryzer; Yasuteru Sano; Takashi Kanda; Vanda Lennon; Richard RansohoffNANOS Annual Meeting 2017: Scientific Platform II
257 A Novel Mechanism for the Central Nervous System Transit of Aquaporin-4 Autoantibody in Neuromyelitis Optica (video)Jeffrey Bennett; Fumitaka Shimizu; Kristin Schaller; Gregory Owens; Anne Cotleur; Debra Kellner; Yukio Takeshita; Birgit Obermeier; Thomas Kryzer; Yasuteru Sano; Takashi Kanda; Vanda Lennon; Richard RansohoffNANOS Annual Meeting 2017: Scientific Platform Presentations (Session 2)
258 A Novel Minimally Invasive Procedure for Eyebrow Ptosis in Three Cases of Unresolved Facial Nerve PalsyKelsey Donovan; Marielle Mahan; Narieman NikNANOS Annual Meeting 2023: Poster Session I: Orbital and Eyelid Disorders
259 A Novel Mitochondrial Mutation with Recurrent Inflammatory Optic NeuropathyFiona Costello; John Chen; Matthew Thurtell; Jane Bailey; Katayoun Alikhani; Randy KardonNANOS Annual Meeting 2020: Poster Session I: Clinical Highlights
260 A Novel OPA1 Mutation in Autosomal Dominant Optic AtrophyJordan A. Margo; Jana A. Bregman; Vivian Rismondo
261 A Novel OPA1 Mutation in Autosomal Dominant Optic AtrophyJordan A. Margo; Jana A. Bregman; Vivian RismondoNANOS 2015: Poster Presentations
262 A Novel Superonasal Transconjunctival Approach To Optic Nerve Sheath Decompression Without The Disinsertion Of Extraocular MusclesKevin E. Lai; Kenneth C. Lao; R. Michael Siatkowski; Bradley K. FarrisNANOS 2014: Poster Presentations
263 A Novel Technique for Analysis of Neuroimaging for Early Detection of Communicating HydrocephalusCasey Judge; Collin McClelland; Michael LeeNANOS Annual Meeting 2022: Poster Session I: New Diagnostic Measurement Techniques
264 A Novel Technique for Measurement of Ocular MisalignmentU. Emrah Altiparmak; Krishna Vaitheeswaran; Eric EggenbergerNANOS 2003: Poster Presentations
265 A Novel Treatment Approach in a Case of Mosaic Neurofibromatosis Type 2Aisha A. Mumtaz; Pooja Parikh; Rachid AouchicheNANOS Annual Meeting 2020: Poster Session I: Clinical Highlights
266 A Novel Trial Design to Test Latanoprost in Optic Disc DrusenJesse Gale; Paul Kim; Anthony WellsNANOS Annual Meeting 2021: Poster Session II: Disorders of the Anterior Visual Pathway (Retina, Optic Nerve, and Chiasm)
267 A Painful 6th Nerve Paresis Caused by Metastatic Breast Carcinoma to the ClivusNorah S. Lincoff; P. Rath
268 A Palpable ProblemKara Warden; Charles Ross; Wayne CornblamNANOS 2008: Poster Presentations
269 A Paraneoplastic Syndrome of Combined Optic Neuritis and Retinitis Defined Serologically by CRMP-5-IgGShelley A. Cross, MD; Diva Salomao; Vanda A. LennonNANOS 2002: Scientific Platform Presentations Session 2
270 A Patient Questionnaire to Assess the Psychosocial Impact of Visual Loss in Optic Nerve DisordersRebecca Kay; Matthew KayNANOS 2018: Poster Presentations
271 A Patient with Dual Right Ophthalmic Arteries and Ophthalmic Artery Occlusion Following Meningioma ResectionSusanne Trauzettel-Klosinski, MD; J. Reinhard, MDNANOS 1999: Poster Sesssion
272 A Peculiar Disease with Peculiar Eye MovementsStephen F. Johnson, MDNANOS 1983: Scientific Platform Presentations (Session 2)
273 A Pediatric Case of Tolosa-Hunt SyndromeRaneem D. Rajjoub; Zachary Bergman; Libby Wei; Rachid AouchicheNANOS Annual Meeting 2020: Poster Session I: Clinical Highlights
274 A Phase I Open Label, Dose Escalation Trial Of QPI-1007 Delivered By A Single Intravitreal (IVT) Injection To Subjects With Low Visual Acuity And Acute Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)Bradley J. Katz, MD, PhDNANOS 2013: Platform Presentations (Session II)
275 A Phase I Open Label, Dose Escalation Trial Of QPI-1007 Delivered By A Single Intravitreal (IVT) Injection To Subjects With Low Visual Acuity And Acute Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)Bradley J. Katz; A. Antoszyk; R. P. Singh; R. Gurses-Ozden; S. Erlich; D. Rothenstein; N. Sharon; J. Hodge; L. A. Levin; N. R. Miller; QPI-1007 NAION Study GroupNANOS 2013: Platform Presentations (Session II)
251 - 275 of 8,106